Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

4. august 2026 oppdatert av: Shaklee Corporation

An Observational, Cross-Sectional Study Evaluating the Impact of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

This study will evaluate whether dietary supplement use (> 1 year) is associated with differences in biological age relative to chronological age, as well as differences in metabolic health and functional fitness tests.

Studieoversikt

Detaljert beskrivelse

Using a cross-sectional study design, information will be obtained by biomarker analysis, questionnaires, physical examination, and physical function from a convenience sample of long-term users of dietary supplements. Comparison data for non-users and single multivitamin/mineral and multiple supplement users will be obtained from the National Health and Nutrition Examination Survey (NHANES).

Studietype

Observasjonsmessig

Registrering (Antatt)

300

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Illinois
      • Addison, Illinois, Forente stater, 60101
        • Rekruttering
        • Biofortis Clinical Research

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Participants will be recruited from a database of long-term Sponsor supplement users.

Beskrivelse

Inclusion Criteria:

  • Adults aged 40 years or older.
  • Verified long-term Sponsor supplement use (>1 year).
  • Willing and able to provide informed consent and comply with study procedures.
  • Able to fast overnight (>8 hours) prior to the study visit.
  • Willing and able to travel to the test site.
  • Ambulatory and currently free of injury or other physical impairment that hinders mobility.
  • Willing to use a personal smart phone or computer with internet access and active email address.
  • Willing to adhere to all study procedures and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information.

Exclusion Criteria:

  • Current or recent (within 6 months) diagnosis of cancer except for non-melanoma skin cancer.
  • Participant is pregnant or lactating.
  • Participant has a pacemaker or other implanted electronic device.
  • Any condition the study staff believes would interfere with the participant's ability to provide informed consent or comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Generally healthy adults, 40 years of age and older, who are long-term (>1 year) supplement users
Participants will be long-term users (>1 year) of the Sponsors supplement products
Ingen intervensjon: observasjonskohort

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Difference between biological and chronological age (years) calculated using a validated biological age calculator
Tidsramme: Baseline single assessment for this observational study
Differences will be compared to an NHANES cohort, where possible.
Baseline single assessment for this observational study

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Blood pressure (mm Hg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Heart rate (beats per minute)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body weight (kg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body mass index (kg/m2)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Waist-to-hip ratio
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body fat (%)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Fat-free body mass (kg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Grip strength (kg)
Tidsramme: Single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Single assessment for this observational study
Lower body strength assessed using the chair stand test (total number of stands)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Flexibility assessed using the sit and reach test (distance in inches reached)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Balance assessed using the one-legged stance test (hold time in seconds)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Quality of life as assessed by the CDC HRQOL-4 questionnaire (overall health rating and number of days)
Tidsramme: Single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Single assessment for this observational study
Cognition as assessed by the cognition scale of the Fatigue and Altered Cognition Scale questionnaire (cognition scale total score)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Social connection as assessed by the NIH Social Connection and Isolation Panel questionnaire (total score)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Erin Barrett, PhD, Shaklee Corporation

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

12. mai 2026

Primær fullføring (Antatt)

1. august 2026

Studiet fullført (Antatt)

1. august 2026

Datoer for studieregistrering

Først innsendt

23. juni 2026

Først innsendt som oppfylte QC-kriteriene

4. august 2026

Først lagt ut (Faktiske)

10. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • BIO-2607

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere